Literature DB >> 25270343

Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Yuesi Zhong1, Meihai Deng, Ruiyun Xu.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death internationally, it is necessary to reappraise evidences of HCC cells involving the portal vein, especially considering tumor size.
MATERIALS AND METHODS: Histopathological evidence and dynamic evidences of radiology and cytology from publication were collected and analyzed.
RESULTS: Frequencies of microscopic portal vein involvement (MPVI) and microscopic intrahepatic metastasis (MIM) in resected specimens with single nodule HCC were lower than that of multi nodule HCC, although not significantly. Early HCC (≤1.5 cm) was with extremely low to 0 frequencies of MPVI and MIM. HCC >5 cm showed a tendency of flowing HCC cells into portal vein, which was coincident with significantly high frequency (64.1 %) of MPVI for HCC >5 cm. There were no significant difference of frequencies of MPVI and MIM between groups of tumor ≤2, ≤3, and ≤5 cm.
CONCLUSIONS: Single nodule HCC >5 cm needs anatomic resection and the root of portal vein should be firstly ligated because of tendency of flowing HCC cells into portal vein. For single nodule HCC ≤2 cm, there was a risk of about 16.2 % of MPVI, and a risk of about 16.2-26.4 % of MPVI for those single nodule HCC ≤5 cm, however, there was a risk of extremely low to 0 of MPVI for early HCC (≤1.5 cm). Surgeons have to balance liver reserve and risk of MPVI for HCC ≤5 cm before deciding anatomic or nonanatomic resection.

Entities:  

Mesh:

Year:  2015        PMID: 25270343     DOI: 10.1007/s00268-014-2807-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  68 in total

1.  Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.

Authors:  A Sasaki; Y Iwashita; K Shibata; M Ohta; S Kitano; M Mori
Journal:  Eur J Surg Oncol       Date:  2006-06-21       Impact factor: 4.424

2.  Histological evaluation of intracapsular venous invasion for discrimination between portal and hepatic venous invasion in hepatocellular carcinoma.

Authors:  Masanori Ohashi; Toshifumi Wakai; Pavel V Korita; Yoichi Ajioka; Yoshio Shirai; Katsuyoshi Hatakeyama
Journal:  J Gastroenterol Hepatol       Date:  2009-11-24       Impact factor: 4.029

3.  Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis.

Authors:  D Franco; L Capussotti; C Smadja; H Bouzari; J Meakins; F Kemeny; D Grange; M Dellepiane
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

4.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Early hepatocellular carcinoma as an entity with a high rate of surgical cure.

Authors:  T Takayama; M Makuuchi; S Hirohashi; M Sakamoto; J Yamamoto; K Shimada; T Kosuge; S Okada; K Takayasu; S Yamasaki
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

6.  Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

Authors:  E Adachi; T Maeda; K Kajiyama; N Kinukawa; T Matsumata; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

7.  Surgery for hepatocellular carcinoma: does it improve survival?

Authors:  Jerome H Liu; Pauline W Chen; Steven M Asch; Ronald W Busuttil; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

9.  C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Justin Sangwook Ko; Jae Berm Park; Joon Hyeok Lee; Sung Joo Kim; Seung Woon Paik; Cheol-Keun Park
Journal:  World J Surg Oncol       Date:  2013-04-23       Impact factor: 2.754

10.  Hepatocellular carcinoma: natural history, current management, and emerging tools.

Authors:  Christopher L Tinkle; Daphne Haas-Kogan
Journal:  Biologics       Date:  2012-07-17
View more
  7 in total

1.  Curative management of small HCCs: time to reconsider the rules?

Authors:  François Cauchy; Jacques Belghiti
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

2.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

3.  The Predictors of Microscopic Vessel Invasion Differ Between Primary Hepatocellular Carcinoma and Hepatocellular Carcinoma with a Treatment History.

Authors:  Yukiyasu Okamura; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

4.  A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.

Authors:  Ruby Matsumoto; Kazushi Numata; Nobutaka Doba; Koji Hara; Makoto Chuma; Hiroyuki Fukuda; Akito Nozaki; Katsuaki Tanaka; Yoshimi Ishii; Shin Maeda
Journal:  J Med Ultrason (2001)       Date:  2016-08-30       Impact factor: 1.314

Review 5.  Small hepatocellular carcinoma suppressed by chemotherapy for synchronous gastric carcinoma after laparoscopy-assisted radical distal gastrectomy: A case report and literature review.

Authors:  Chao Wang; Xin Luo; Shui-Lin Dong; Chao Leng; Bi-Xiang Zhang; Bin-Hao Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Precision surgery for primary liver cancer.

Authors:  Takeshi Takamoto; Masatoshi Makuuchi
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

7.  Macroscopic Portal Vein Thrombosis in HCC Patients.

Authors:  Hikmet Akkiz; Brian I Carr; Sedef Kuran; Ümit Karaoğullarından; Oguz Üsküdar; Salih Tokmak; Burcu Arslan; Figen Doran; Hüseyin Tugsan Balli; Abdulalh Ülkü; Tolga Atılgan Akçam; Halil İbrahim Bahçeci; Kamil Yalçın Polat; Necati Örmeci; Halis Şimşek; Abdullah Sonsuz; Ali Demir; Engin Altıntaş; Mehmet Demir; Kendal Yalçın; Nazım Ekinci; Ayşegül Harmancı Özakyol; Mehmet Yücesoy; Ahmet Uygun; Vito Guerra; Anıl Delik; Yaman Tokat; Sezai Yilmaz; Ahmet Bektaş; Murat Kılıç
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.